PRESERVE-Zenith® Branch Endovascular Graft-Iliac Bifurcation Clinical Study
Study Details
Study Description
Brief Summary
The purpose of this extended study is to evaluate the safety and effectiveness of the Zenith® Branch Endovascular Graft-Iliac Bifurcation in combination with the commercially available Atrium iCAST™ covered stent in patients in a treatment of aortoiliac and iliac aneurysms.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Experimental: Zenith® Branch Endovascular Graft-Iliac Bifurcation Zenith® Branch Endovascular Graft-Iliac Bifurcation in combination with the Atrium iCAST™ and the Zenith® Flex AAA Endovascular Graft |
Device: Zenith® Branch Endovascular Graft-Iliac Bifurcation,
Implantation of the Zenith® Branch Endovascular Graft-Iliac Bifurcation.
Other Names:
Device: Atrium iCAST™
Implantation of Atrium iCAST
Device: Zenith® Flex AAA Endovascular Graft
Implantation of the Zenith Flex Endovascular Graft
|
Outcome Measures
Primary Outcome Measures
- Number of patients with freedom from patency-related intervention defined as a secondary intervention to treat a > 60 % stenosis of the internal iliac artery associated with clinical symptoms. [6 months]
Secondary Outcome Measures
- Freedom from morbidity (i.e., morbidity index) [30 days]
Morbidity index based on a composite endpoint of 31 pre-specified measure elements in seven categories (i.e., cardiovascular, pulmonary, renal, bowel, wound, neurologic, and vascular).
Eligibility Criteria
Criteria
Inclusion Criteria:
-
An aortioiliac or iliac aneurysm
-
An unsuitable distal sealing site for a traditional Zenith iliac leg graft within the common lilac artery
Exclusion Criteria:
-
Less than 18 years of age
-
Inability or refusal to give informed consent
-
Disease considerations that would compromise patient safety or study outcomes
-
Pregnant, breast-feeding or planning on becoming pregnant prior to completion of the study
-
Unwilling or unable to comply with the follow-up schedule
-
Simultaneously participating in another investigative device or drug study
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Mayo Foundation for Medical Education and Research | Phoenix | Arizona | United States | 85054 |
2 | VA Palo Alto HCS | Palo Alto | California | United States | 94304 |
3 | Stanford University Medical School | Stanford | California | United States | 94305 |
4 | Christine E. Lynn Heart and Vascular Institute | Boca Raton | Florida | United States | 33431 |
5 | South Florida Medical Imaging | Fort Lauderdale | Florida | United States | 33308 |
6 | University of Florida | Gainesville | Florida | United States | 32610 |
7 | Emory University Hospital | Atlanta | Georgia | United States | 30322 |
8 | St. Anthony's Medical Center | Rockford | Illinois | United States | 61108 |
9 | Methodist Hospital of Indiana | Indianapolis | Indiana | United States | 46202 |
10 | University of Kentucky Hospital | Lexington | Kentucky | United States | 40536 |
11 | University of Massachusetts | Worcester | Massachusetts | United States | 01655 |
12 | William Beaumont Hospital | Royal Oak | Michigan | United States | 48073 |
13 | Mayo Clinic | Rochester | Minnesota | United States | 55905 |
14 | Washington University School of Medicine | Saint Louis | Missouri | United States | 63110 |
15 | Mercy Hospital East Communities | Saint Louis | Missouri | United States | 63141 |
16 | University of Nebraska | Omaha | Nebraska | United States | 68105 |
17 | Dartmouth Hitchcock Medical Center | Lebanon | New Hampshire | United States | 03756 |
18 | Columbia University Medical Center | New York | New York | United States | 10032 |
19 | Weill Cornell Medical Center | New York | New York | United States | 10065 |
20 | University of North Carolina | Chapel Hill | North Carolina | United States | 27599 |
21 | Cleveland Clinic Foundation | Cleveland | Ohio | United States | 44195 |
22 | Hospital of the University of Pennsylvania | Philadelphia | Pennsylvania | United States | 19104 |
23 | Allegheny General Hospital | Pittsburgh | Pennsylvania | United States | 15212 |
24 | University of Pittsburgh Medical Center | Pittsburgh | Pennsylvania | United States | 15213 |
25 | Medical University of South Carolina | Charleston | South Carolina | United States | 29425 |
26 | UT Southwestern | Dallas | Texas | United States | 75235 |
27 | University of Virginia | Charlottesville | Virginia | United States | 22908 |
28 | Aurora St. Luke's Hospital | Milwaukee | Wisconsin | United States | 53215 |
Sponsors and Collaborators
- Cook Research Incorporated
Investigators
- Principal Investigator: W. Anthony Lee, MD FACS, Christine E. Lynn Heart and Vascular Institute
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- 05-625 P2